Paper digest: Tracking CAR-T cells after infusion
The Paper Digest series highlights outstanding publications demonstrating the advanced use of flow cytometry in clinical research. Here you will find core elements from the work of Blache et al., Front Immunol. 2021, describing a standardized, yet flexibly adaptable framework for identification and comprehensive characterization of CAR-T cells post infusion.
Methodical focus refers to pre-analytical and analytical cytometry process phases.
Cytometry process phases
Pre-formulated dry antibody assays for flow cytometry
Benefit
- Reduction of technical error
- Expert antibody panel design
- Flexible panel adaptation
- Fast turnaround time
- Easy reagent storage
Comprehensive CAR-T Cell Phenotyping
Differential Activation/Exhaustion Marker Profiles Between CAR-/+ T Cells
healthy control CAR-
patient T-cells CAR-
patient T-cells CAR+
How this study was performed
Whole blood samples from CAR-T recipients and normal donors were stained with DURAClone dry reagents* IM Count, IM TCRs, RE ALB and LUCID custom dry reagents* together with liquid Drop-in reagents. Analyzed with Kaluza software*.
Talk to an expert
Talk to an expert
Blache U, Weiss R, Boldt A, Kapinsky M, Blaudszun AR, Quaiser A, Pohl A, Miloud T, Burgaud M, Vucinic V, Platzbecker U, Sack U, Fricke S, Koehl U. Advanced Flow Cytometry Assays for Immune Monitoring of CAR-T Cell Applications. Front Immunol. 2021 May 3;12:658314, reproduced pursuant to Creative Commons 4.0 Creative Commons Attribution 4.0 International License.
*For research use only. Not for use in diagnostic procedures.